CLINICAL STUDIES ON TMS-19-Q·GC TABLET IN DERMATOLOGICAL SUPERFICIAL INFECTION
-
- FUJITA KEIICHI
- Department of Dermatology, National Defence Medical College
-
- KIMURA YASUTAKA
- Department of Dermatology, National Defence Medical College
-
- SEKINE RUMIKO
- Department of Dermatology, National Defence Medical College
Bibliographic Information
- Other Title
-
- 表在性皮膚感染症に対するTMS-19-Q・GC錠の臨床的検討
Abstract
TMS-19-Q·GC tablet, a new developed macrolide antibiotic, was administered to 21 patients, 7 with folliculitis, 7 with furuncle, 3 with infectious atheroma and 4 with subcutaneous abscess at daily dose of 300mg or 400mg for 7-33 days.<BR>The results were summarized as follows: Cured in 15 cases, markedly improved in 3 cases, moderately improved in 3 cases.<BR>Effectiveness rate was 100% and neither side effect nor abnormal laboratory finding was observed in any case.
Journal
-
- CHEMOTHERAPY
-
CHEMOTHERAPY 32 (Supplement6), 505-509, 1984
Japanese Society of Chemotherapy
- Tweet
Details 詳細情報について
-
- CRID
- 1390282681258295168
-
- NII Article ID
- 130004194625
-
- ISSN
- 18845894
- 00093165
-
- Data Source
-
- JaLC
- CiNii Articles
-
- Abstract License Flag
- Disallowed